Periodontal diseases are complex inflammatory diseases and affect up to 20% of the worldwide population. An unbalanced reaction of the immune system toward microbial pathogens is considered as the key factor in the development of periodontitis. Defensins have a strong antimicrobial function and are important contributors of the immune system toward maintaining health. Here, we present the first systematic association study of DEFB1. Using a haplotype-tagging single nucleotide polymorphism (SNP) approach, including described promoter SNPs of DEFB1, we investigated the associations of the selected variants in a large population (N ¼ 1337 cases and 2887 ethnically matched controls). The 3 0 untranslated region SNP, rs1047031, showed the most significant association signal for homozygous carriers of the rare A allele (P ¼ 0.002) with an increased genetic risk of 1.3 (95% confidence interval: 1.11-1.57). The association was consistent with the specific periodontitis forms: chronic periodontitis (odds ratio ¼ 2.2 (95% confidence interval: 1.16-4.35), P ¼ 0.02), and aggressive periodontitis (odds ratio ¼ 1.3 (95% confidence interval 1.04-1.68), P ¼ 0.02). Sequencing of regulatory and exonic regions of DEFB1 identified no other associated variant, pointing toward rs1047031 as likely being the causative variant. Prediction of microRNA targets identified a potential microRNA-binding site at the position of rs1047031.
Introduction
Parodontopathies are highly prevalent 1 and, according to the WHO, affect human populations worldwide at prevalence rates of up to 20%. 2 They are caused by an unbalanced immune reaction toward environmental and behavioral effects. A pathogenic microflora is the causative agent for the development of parodontopathies, but a poor oral hygiene and most importantly, smoking 3 also contribute strongly to the disease risk. Periodontitis is a complex chronic inflammatory disease of the periodontium, which results in a loss of connective tissue and bone support of the teeth and has been shown in epidemiological studies to have a co-morbidity with coronary heart disease and diabetes. 4 Chronic periodontitis (CP) is one of the most common forms of parodontopathies and the major cause of tooth loss in adults above 40 years. Advanced forms are characterized by inflammation that extends deep into the tissues of the periodontium, a process that eventually causes the loss of the supporting connective tissue and the alveolar bone. Aggressive periodontitis (AgP) is the most severe form of parodontopathies, characterized by a rapid progression with a particularly early age of onset (generally o35 years).
Defensins are proteins secreted by the immune system, which help to maintain the balance between healthy state and disease condition in the complex environment of the mouth, 5 and have broad-spectrum antimicrobial activity against bacteria, fungi and some viruses. 6 The human b-defensin genes (DEFB) are clustered on chromosome 8p23.1 and show considerable variations in copy number except for DEFB1, which has only two copies per diploid genome. 7 This makes DEFB1 accessible to straightforward association analysis of potential genetic susceptibility variants. Consistent with all human epithelial tissues tested to date, including intestinal mucosa, 8 the urogenital tract, 9 and airway epithelia, 10 DEFB1 is constitutively expressed in the gingival epithelial tissues. 11 It is inducible only by commensal bacteria and not, unlike hBD-2 and DEFB103, by pathogenic bacteria. 12 Therefore, DEFB1 has been suggested to be responsible for maintaining a healthy status in mucosal epithelials before infection with pathogenic bacteria, and can thus be considered to function as a guardian in the maintenance of mucosal and oral health.
Accordingly, associations of specific single nucleotide polymorphisms (SNPs) of DEFB1 with inflammatory and allergic diseases of host-environment interfaces, such as mucosal surfaces of intestines (Crohn's disease), 13 respiratory tracts (asthma) 14 and the skin (atopic dermatitis) 15 have been, sometimes ambiguously, described. It is well accepted that genetic factors also have a major function in the increased susceptibility to periodontitis, 16, 17 although the inherited risk variants have largely remained unexplained, [16] [17] [18] which seems to be largely due to the fact that most studies were under-powered for proper interpretation.
To analyze the role of antimicrobial peptides in periodontal diseases, we explore the potential associations of nine DEFB1 haplotype-tagging SNPs and its common promoter SNPs rs11362, rs1800972 and rs1799946 in a large clinical analysis population. We give evidence for the relevance of the variant rs1047031 in periodontal disease development in independent populations of specific parodontopathic disease forms CP and AgP. This finding supports the hypothesis that DEFB1 is a crucial gene in the pathophysiology of periodontitis, and may prompt the reconsideration of evidence related to DEFB1 in disease susceptibility observed in previous association studies of other complex inflammatory diseases of the interfaces.
Results
In an explorative study, we genotyped 1337 periodontitis cases and 2887 ethnically matched controls (Table 1) . We selected nine haplotype-tagging SNPs of DEFB1 covering two exons and the intervening intron of the 463-bp long mRNA encoding gene, including potentially upstream and downstream regulatory sequences (Figure 1 ). In addition, we analyzed associations of the 5 0 UTR SNP G-20A (rs11362), C-44G (rs1800972) and G-52A (rs1799946), two of which have been earlier subjected to candidate gene association studies in patients with severe CP and early onset periodontitis (see Table 2 ). 19, 20 Before adjustment for covariates: smoking, diabetes and the potential confounder gender using logistic regression analysis, five haplotype-tagging SNPs (rs1047031, rs2293958, rs2980930, rs5743401 and rs5743402) and the promoter SNP rs1800972 gave evidence for association with periodontitis (Supplementary Table S1 ). We next adjusted for covariates: smoking, diabetes and gender using logistic regression analysis. Subsequently, we corrected for multiple testing using conservative Bonferroni thresholds that corresponded to an uncorrected significance level of a ¼ 0.05. After covariate adjustment and correction for multiple testing, the haplotype-tagging SNPs rs1047031, rs2293958, rs2980930 and rs5743401 remained significant. SNP rs1800972 marginally missed significance after correction for multiple testing ( Table 2 ). The highest difference in allele frequencies between cases and controls was seen for SNP rs1047031 with an allele frequency of 17.1% in controls and 20.5% in cases (Table 3) .
To test whether the observed associations were present in sub-forms CP and AgP independently, we investigated the allele frequencies for the associated variants in 805 CP cases and 1153 controls, and in 532 AgP cases and 1472 further controls, separately. The 3 0 UTR variant rs1047031 and the intronic SNP rs2293958 gave evidence for an association in CP as well as in AgP before covariate adjustment (Supplementary Table S1 ). On adjustment for smoking, diabetes and gender, only one SNP, rs1047031, remained significantly associated in both populations (Table 4) . For this variant, the effect of the rare A allele was highly similar to that seen in the unadjusted analysis, and it increased the genetic risk the homozygous carriers with an odds ratio (OR) of 2.2 (95% confidence interval (CI): 1.2-4.3, P ¼ 0.021) for the CP population and of 1.3 (95% CI: 1.0-1.7) for the AgP population ( Table 4) . The rare allele for rs1047031 had a frequency of 20.0% in CP cases and 16.7% in CP controls. In the second case-control panel of the more severely affected AgP patients, the minor allele frequency was 21.2% compared with 17.5% in controls (Table 5) . For 84 AgP patients, the diabetes status was unknown (Table 1) . To exclude a systematic bias in the pattern of missing values with a potentially confounding effect, we estimated minor allele frequencies for the significant SNPs in patients of unknown diabetes status (N ¼ 84), and compared them with the AgP case population known to be free of diabetes (N ¼ 442). There were only small differences between the two groups, with a minor allele frequency of 21.2% for SNP rs1047031 in diabetes-free AgP patients, and a minor allele frequency of 20.0 % in AgP patients with unknown diabetes status.
To choose the genetic model that could best explain the underlying association, we used Akaike's Information Criterion for describing the model fit in the logistic regression analysis. Akaike's Information Criterion is an established statistical criterion, which is known to be robust in identifying a sparse statistical model that nevertheless fits the data well. In our analysis, autosomal recessive and multiplicative genetic risk models showed the best model fit and suggested a mode of inheritance that is likely to be in-between the two models (Supplementary Table S2 ).
In earlier studies, the promoter SNPs: G-20A (rs11362) 20 and C-44G (rs1800972) 19 were subjected to candidate gene association studies in patients with severe CP and early onset periodontitis. In these studies, no association with periodontitis was observed. In our analysis, we observed an association of rs1800972 marginally missing the significance threshold (P ¼ 0.051 after correction for multiple testing; Table 2 ). Thus, we analyzed associations of rs11362, rs1800972 and of the adjacent SNP G-52A (rs1799946) in CP and AgP separately, although they were not significantly associated in the combined population. This analysis showed that SNP rs1800972 had only a very marginally lower allele frequency (22.5%) in the less severely affected CP cases than in the two control panels (23.6% and 23.0%). Instead, this borderline association was driven by the low frequency of the rare G allele in AgP cases (19.3%; Table 5 ). Accordingly, in the AgP panel, SNPs rs1800972 and rs1799946 showed a statistically significant evidence for association with AgP before and after adjustment (for association statistics before adjustment for covariates, see Supplementary Table S3 ). For rs1800972, this was P multiplicative ¼ 0.0017 with an OR of 0.7 (95% CI: 0.6-0.9), and for rs1799946 this was P recessive ¼ 0.0121 and P multiplicative ¼ 0.0075 with an OR of 1.5 (95% CI: 1.1-2.2) and 1.3 (95% CI: 1.1-1.5), respectively (Table 6 ).
In search of additional disease-associated mutations in the DEFB1 gene, we resequenced the two exons, splice sites and the promoter region in the genomic DNA of 47 individuals with AgP. No other associated SNP was identified at the nominal 0.05 significance level.
Subsequently, we performed a haplotype analysis using the four SNPs that remained significant in the pooled periodontitis population after Bonferroni correction for multiple testing. Of these, five haplotypes could be inferred, four of which had a frequency X2%. For two haplotypes, the frequency distribution showed a significant difference between cases and controls after 100 000 permutations. In particular, the CATT haplotype composed of rs2980930-C, rs1047031-A, rs2293958-T and rs5743401-T alleles was 3.4% more frequent in cases (P ¼ 0.0012), and the reciprocal GGAC haplotype was 2.6% more frequent in controls (P ¼ 0.037). The best single SNP association of the rs1047031-A allele had a nominal P-value (P ¼ 0.0012), which was identical to the CATT haplotype, indicating that this SNP explained most of the association within this region.
To identify a possible causal effect of the G-A nucleotide transition of SNP rs1047031, we analyzed the secondary structure of the mRNA (Vienna RNA Package 1.7.2.; http://rna.tbi.univie.ac.at/). The exchange had no effect on the mRNA folding and only marginally lowered the minimum free energy of the optimal secondary structure from À139.92 to À140.82 kcal mol
À1
. A prediction for microRNA targets (microRNA resource; http://www.microrna.org) identified a potential binding site of hsa-miR-1237 at the position of SNP rs1047031 with 80% homology (Figure 2 ). The nucleotide exchange resides within a potential 3 0 binding site of the microRNA hsa-miR-1237 (MI0006327) and introduces a mismatch at the 2nd position.
Discussion
These data provide evidence for a significant association of the rare A allele of the DEFB1 3 0 variant rs1047031 with an increased risk for periodontal diseases. This association was independent of the periodontitis-specific covariates: smoking, diabetes and gender. The robustness of these data was further supported by a separate analysis of the two parodontopathic distinct forms: CP and AgP. Both independent case populations differed only marginally in terms of allele frequencies and contributed in a Earlier studies on periodontitis investigated associations of SNP G-20A (rs11362) 20 and C-44G (rs1800972) 19 with patients with severe CP and those with early onset periodontitis (currently most likely classified as AgP), respectively. These studies were of much smaller sample size than this study and observed no disease association. In our analysis of the pooled population, we observed an association marginally missing the significance threshold for rs1800972. A separate analysis of the two distinct subphenotypes, CP and AgP, showed that this borderline association was primarily driven by the low frequency of the rare G allele in AgP cases (19.3%) in contrast to CP cases (22.5%) when compared with the two control panels (23.6 and 23.0%). Interestingly, another study proposed a protective effect of the rare rs1800972 allele 
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AS Schaefer et al on the carriage of Candida species. 24 Considering that individuals who experienced early development of periodontitis are likely to have inherited a major genetic disease variant, it is conceivable that larger CP populations may also show a positive association with this promoter variant. To clarify this, further replication experiments in larger populations of AgP and CP would be desirable.
The three promoter variants have further been subject to several other association studies on different diseases. In the past, these promoter SNPs were analyzed in association studies on Crohn's disease (positive association with rs11362 and rs1800972 13 ), airway colonization in cystic fibrosis (positive association of rs11362 and rs1799946), 25 HIV infection (associations of rs1799946, 26 rs11362 27 and rs1800972 28 ) and chronic obstructive pulmonary disease (no association). 29 However, these studies were characterized by small sample sizes and studies did not replicate the observed associations, except for associations with HIV, which were identified in different, albeit small populations of mixed ethnicity. The promoter sequence is a region of low linkage disequilibrium because of high recombination rates (r 2 o0.41), which could explain the varying allele frequencies and genetic effects for the same SNPs described in the cited studies. 
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The question arises as to how would the rs1047031 variant impair the normal function of DEFB1 in the maintenance of the epithelial barrier. SNP rs1047031 is located 5 bp inside the 3 0 UTR. Sequencing of the complete translated sequence including the 5 0 and 3
0
UTRs has identified no further significantly associated polymorphisms. Thus, it could be speculated that SNP rs1047031 itself may have a potential functional effect on the increased susceptibility to periodontal diseases. The 3 0 UTRs of human protein-coding genes are rich in microRNA (miRNA) target sites. It has been proposed that the miRNA regulation may be affected by polymorphisms in 3 0 UTRs. 30 miRNA target prediction of 3 0 UTR variants of DEFB1 indicated that the G-A nucleotide transition could influence the putative 3 0 binding site of the miRNA hsa-miR-1237. Although there is still a debate on the actual role of DEFB1 and the potential inducibility of DEFB1 by microbial pathogens, it is likely that some DEFB1 regulatory mechanisms exist to aid the maintenance of healthy status in the mucosal epithelials. In this regard, although speculative, the disease-associated variant could interfere with a potentially specific miRNA-mediated posttranscriptional regulatory mechanism, and might affect the binding efficiency of this or another yet unknown miRNA. It is also possible that we missed the true or an additional causal variant located within the large intron or within intergenic sequences distal or proximal to DEFB1, which was neither sequenced nor covered by a tagging SNP. Here, in addition to the replication of our finding in another large independent analysis of AgP and CP populations, further comprehensive studies are required. Abbreviations: CI, confidence interval; OR, odds ratio; SNP, single-nucleotide polymorphism. Association statistics are shown for the sub-phenotypes chronic and aggressive periodontitis. For table description see Table 2 . Furthermore, functional studies to verify a potential genotype-specific effect on miRNA binding are necessary to demonstrate a potential causal effect of this variant.
In conclusion, to the best of our knowledge, this study reports for the first time an association of a 3 0 UTR variant of DEFB1 in large independent populations of the two specific sub-forms CP and AgP.
Patients and methods

Subjects
Patient and control samples for the CP and AgP association studies were recruited across Germany and the Netherlands (Table 1 ). All radiographs were analyzed by one calibrated dental examiner, who had been extensively trained by an experienced periodontist. Only individuals of German and Dutch ethnicity were included, judged on the basis of the location of both parental birthplaces. The genetic sub-structure of the German population has been assessed in a previous study, 31 indicating only negligible sub-structures and therefore allowing a joint analysis of all German individuals. Written informed consents were obtained from all subjects recruited into this study. The study was approved by the ethical review board of each participating institute (Medical Ethical Committee, Universities of Bonn, Dresden, Kiel and Munich, Germany, and Medical Ethical Committee, Academic Medical Center, University of Amsterdam, The Netherlands). The diagnosis of CP or AgP was made according to the criteria established at the 1999 international classification workshop. 32 In addition, the following inclusion criteria were used: Northern German CP patients were required to be older than 40 years at the time of diagnosis. Probing pocket depth, attachment level and furcation involvement were measured and bleeding upon probing was registered. The dimension of bone loss was assessed by means of dental radiographs and/or orthopantomographs. The percentage of bone loss was measured for each tooth based on the length of the roots. Patients presenting probing depths X5 mm with more than 30% bone loss for, at least, three teeth were included in the study.
Southern German CP patients were diagnosed based on a standardized clinical examination protocol, including the evaluation of (1) the probing pocket depth measured at six locations on each tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual and disto-lingual) using a Michigan type 'O' probe, (2) the involvement of furcation using a Naber-type probe, (3) bleeding on probing; registered as present or absent, and (4) bone loss as assessed by orthopantomographs. The probing pocket depth was determined from the free gingival margin to the base of the periodontal pocket keeping the probe in line with the long axis of the tooth. The furcation defects were examined by horizontal probing from the furcation entrance to the base of the defect. The furcation involvement was classified according to the protocol of Hamp et al. 33 All patients included in this periodontitis group met the following clinical criteria: (1) a total of at least 15 teeth in situ, (2) X8 teeth with a probing pocket depth of X5 mm, at least, at one location and/or a furcation involvement Xclass II and (3) radiographic evidence of bone loss. The Dutch CP patient cohort is a collection of three study groups as previously described. [34] [35] [36] Inclusion criteria for the German and Dutch AgP patients were age at diagnosis p35 years and X2 teeth with X50% periodontal bone loss. A set of full-mouth dental radiographs or panorex was available for confirmative periodontal bone scoring. A total of 368 German (133 males, 224 females and 11 of unknown gender) and 164 Dutch AgP patients (44 males and 120 DEFB1 disease association AS Schaefer et al
